Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2
This study is a prospective, open-label, multicenter study in previously un...
Status
Recruiting
Location
The Affiliated Hospital of Xuzhou Medical University
LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
PHASE4
Main objective:
* To evaluate the applicability of the treatment:
1. To...
Observational Study for Patients With Newly Diagnosed (MCL) Not Eligible for High-dose Therapy
N/A
This is an observational study aimed to analyze the effectiveness of treatm...
Status
Completed
Location
Multiple Locations
Start Date
2012-04-01
Trial ID
NCT03054883
To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL)
PHASE1
This is an open-label, multicenter study to evaluate safety and tolerabilit...